Abatacept reduces fatigue and pain severity and sleep problems through 2 years in rheumatoid arthritis patients in the AIM and ATTAIN trials

Category Primary study
JournalJournal of Rheumatology
Year 2008
This article has no abstract
Epistemonikos ID: 16709b2c19f0e98187e84bb0e6f55e9ca1dc4a4f
First added on: Oct 21, 2017